(Q40105438)

English

Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, beta-lapachone

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, beta-lapachone (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit